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ABSTRACT

Article Type:

Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus, started in livestock within
the markets of Wuhan, China and was consequently spread around the world. The virus has been
rapidly spread worldwide due to the outbreak. COVID-19 is the third serious coronavirus outbreak
in less than 20 years after Severe Acute Respiratory Syndrome (SARS) in 2003 and Middle East
Respiratory Syndrome (MERS) in 2012. The novel virus has a nucleotide identity closer to that of
the SARS coronavirus than that of the MERS coronavirus. Since there is still no vaccine, the main
ways to improve personal immunity against this disease are prophylactic care and self-resistance
including an increased personal hygiene, a healthy lifestyle, an adequate nutritional intake, a
sufficient rest, and wearing medical masks and increasing time spent in well ventilated areas. There
is a need for novel antivirals that are highly efficient and economical for the management and
control of viral infections when vaccines and standard therapies are absent. Herbal medicines and
purified natural products have the potential to offer some measure of resistance as the development
of novel antiviral drugs continues. In this review, we evaluated 41 articles related to herbal products
which seemed to be effective in the prevention or treatment of COVID-19.
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Implication for health policy/practice/research/medical education:

Some herbal products seemed to be effective in the prevention or treatment of COVID-19.
Please cite this paper as: Tolouian A, Khosravian M, Ragati Haghi H, Bolourian A, Mojtahedi Z, Asgharpour M. Herbal
medicines in the treatment of coronavirus disease 2019 (COVID-19). J Nephropharmacol. 2021;10(2):e18. DOI: 10.34172/
npj.2021.18.

Introduction
Coronavirus disease 2019 (COVID-19), caused by a novel
coronavirus, started in livestock within the markets of
Wuhan, China and was consequently spread around the
world in December 2019. It can be transmitted from one
person to another through sneezing or physical contact.
COVID-19 mainly affects the respiratory system with
symptoms such as cough, fever and shortness of breath.
In most cases, the disease is mild; however, it may lead
to respiratory failure in some patients, particularly in the
elderly and those with co-morbidities, such as diabetes
or obesity (3). When it progresses to respiratory failure

or acute respiratory distress syndrome (ARDS), it often
comes with multi-organ dysfunction and a disturbed
immune system; in addition, it often comes with lower
levels of lymphocytes, especially natural killer (NK) cells
and extremely high inflammatory parameters, including
C-reactive protein (CRP) and pro-inflammatory cytokines
(IL-6, TNFα and IL-8) (1-3).
COVID-19 is the third serious coronavirus outbreak
in less than 20 years. The first two were Severe Acute
Respiratory Syndrome (SARS) in 2003 and Middle East
Respiratory Syndrome (MERS) in 2012. Nucleotide
identity of COVID-19 to the SARS coronavirus is almost
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80% as compared to 52% with MERS coronavirus, that
is COVID-19 is much closer in construct to the SARS
coronavirus than to MERS coronavirus. Angiotensinconverting enzyme 2 (ACE2) acts as a functional receptor
on the surface of cells for the entry of SARS coronavirus
and COVID-19 into the body (3). At present, it is
important to control the source of infection, to cut off
the transmission route, and to administer effective drugs
that can control the progress of the disease proactively.
Currently, the drug therapy for COVID-19 is mainly
comprised of four antiviral drugs, traditional medicines,
immune-enhancement therapy and viral-specific plasma
globulin.
Antivirals, respiratory supportive therapies and
sometimes anti-inflammatory drugs have been the main
treatments of severe cases of COVID-19. Promising
ongoing clinical trials for COVID-19 include interferon,
lopinavir/ritonavir, ribavirin, Arbidol, remdesivir,
tocilizumab, glucocorticoids, IL-6 antagonist, JAK
inhibitors
and
chloroquine/hydroxychloroquine,
pseudoephedrine, rographolide, abacavir, oseltamivir
and thalidomide, though none of them have shown to
be universally effective (1-6). Hence, there is a vital need
to discover the novel antivirals that are highly efficient
and economical for the control and management of viral
infections when vaccines and standard therapies are not
available. Herbal medicines and purified natural products
seem to play role in developing the new antiviral drugs. In
this review, we evaluated herbal products that have been
effective in preventing or treating COVID-19.
Materials and Methods
To collect data, a variety of sources were scrutinized such
as, PubMed, Scopus, Embase, Google Scholar and Web
of Science. To this end, the following keywords and their
equivalents were searched through the aforementioned
sources: COVID-19, herbal medicines, flavonoids,
coronavirus disease 2019 and angiotensin-converting
enzyme 2.
Treatment of COVID 19 based on antiviral herbal
medicine treatment
Herbal medicine is purely originated from nature, so it
tends to induce fewer side effects (6). Many substances
derived from plants, such as flavonoids, alkaloids, and
terpenoids, have biological effects in vitro and in vivo.
Along with the biological activities of the natural products
derived from plants, the anti-inflammatory, antiviral,
antiplatelet, antitumor, anti-allergic and antioxidant
activities should also be considered. However, most of the
reports have assessed the effects of these compounds in
experimental models, and clinical trials are rare on this
subject.
To shed some lights on this issue, there is an essential
need to investigate the influence of herbal medicines on
coronavirus.; In addition, the magnitude of this essence is
2
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highlighted because of rapid expansion and epidemics of
COVID-19 infection, increased public concern about the
transmission of the disease, lack of knowledge concerning
the definitive treatment and the need for safe treatment
at home. Although the review of some research articles
such as one by Santana et al emphasizes the beneficial and
fruitful effects of various natural products on pulmonary
diseases in both experimental cases or human cases, there
is not any unanimous consensus over this issue (7).
Prevention
Currently, the only way to prevent the spread of COVID-19
is infection control through hand washing, cleaning,
disinfecting, sterilizing, and wearing masks. Therefore,
prophylactic care or self-resistance is the main way to
maintain personal immunity to the disease. Patients with
underlying diseases such as hypertension, diabetes, heart
disease and cancer are at higher risk due to respiratory
system problems and their weak immune system
responses because of their specific drug consumptions.
Thus, self-resistance in these patients who constitute the
most vulnerable population is of utmost importance.
Prevention of infectious diseases by traditional medicine
has been recorded for many decades in Chinese history
Similarly, previous studies on the prevention of SARS
have been conducted by traditional Chinese medicine.
Five of the most commonly used plants in traditional
medicines include; astragalus, liquorice, fangfeng, baizhu
and honeysuckle. In addition, other studies have shown
that vitamin C, vitamin D and vitamin E supplementation,
may increase resistance against coronavirus (8). Moreover,
these traditional medicines are cost-effective approaches
to prevent the spread of COVID 19.
Targeting ACE2 has been considered to be an
alternative for preventing and inhibiting COVID-19
infection (3). Inhibiting the ACE2 receptor through using
Chinese herbal medicine due to the low toxicity and
high availability could be to be an alternative for treating
COVID-19 (8). Molecular docking was used by Chen et al
to find natural compounds for targeting the ACE2 receptor.
They proposed five components with anti-virus activity
including scutellarin, baicalin, hesperetin, nicotianamine
and glycyrrhizin that could prevent COVID- 19 infection
(9).
Among the large number of Chinese herbal components,
Emodin (6-methyl-1,3,8-trihydroxyanthraquinone) was
identified as an effective ingredient of polygonaceae to
prevent the interaction of the SARS coronavirus protein
with the ACE2 receptor and to reduce the severity of the
infection. It is suggested that viral ion channels may be
a good target for the development of antiviral agents.
However, the pathway for the reach of the virus into
its target cells is not completely blocked, and the virus
may enter through other receptors, , as a result, further
investigations are needed to be conducted on other
cellular entry modes (10,11).
http://www.jnephropharmacology.com
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An alternative approach to the prevention of
COVID-19 in high-risk populations may be based on
previous evidence about viral treatments which has been
proposed by traditional Chinese medicine. Huangdi’s
Internal Classic, an ancient Chinese book about medicine,
reported about preventive effects of herbal medicine on
infectious disease epidemics. In their book, Huangdi and
his physician talk about the balancing of wind, heat, and
dampness, which are the main principles of using Chinese
medicine (12). Herbs with these historical origins used for
the prevention of COVID-19 are Rhizoma Atractylodis
Macrocephalae (Baizhu), Radix glycyrrhizae (Gancao),
Radix saposhnikoviae (Fang Feng), Radix astragali
(Huangqi), Lonicerae Japonicae Flos (Jinyinhua), and
Fructus Forsythia (Lianqiao) (13).
Lau et al investigated a herbal formula (Yupingfeng
Powder plus Sangju Decoction) for prevention of SARS
with 16437 hospital care workers, 1063 of whom took the
herbal formula (herbal group) while 15374 of whom did
not (non-herbal group). None of the participants in the
herbal group developed SARS disease, while 0.4% of the
participants in the non-herbal group developed SARS
(14). In two hospitals in Beijing, China, Xu et al (15) and
Zhang et al (16) conducted studies in which a formula of
Yupingfeng powder mixed with some heat-clearing and
detoxifying herbs. In one hospital, 163 subjects used the
powder for 6 days, and in the other hospital, 3561 subjects
took it for 12- 25 days. The outcomes of these two studies
revealed that none of these subjects developed SARS
disease.
Treatment of cough, breathless and asthma
Traditional medicine often recommends a combination of
three different strategies including lifestyle modification,
herbal remedies and manual procedures for the
treatment of diseases. The guidelines recommend herbal
medicines alone or often in a combination. For example,
a combination of Plantago major seed with its antioxidant
and anti-inflammatory has effect on lungs, as well as, a
combination of Almond gum with its anti-ulcerogenic
has influence on the gastrointestinal epithelium, both of
which were well-tolerated and deemed potentially useful
for patients of 28 participants with refractory asthma in
trail (17).
A murine model study assessed the effects of the Chinese
herbal formula, PM014 (contains Schizandra chinensis,
Stemona sessilifolia, Asparagus cochinchinensis, Rehmannia
glutinosa, Scutellaria baicalensis, Prunus armeniaca, and
Paeonia suffruticosa), on lipopolysaccharide induced,
chronic obstructive pulmonary disease. It was confirmed
that PM014 improved the lung inflammation markers
and decreased accumulation of immune cells and levels
of TNF-α and IL-6 in bronchoalveolar lavage fluid (18).
A study on 76 discharged patients in China, showed that
the average time of hospitalization decreased in 59 cases
after treatment with Qingfei Paidu decoction. In addition,
http://www.jnephropharmacology.com

the thoracic computed tomography scan (CAT scan)
indicated the improvement of inflammatory lesions by
Qingfei Paidu decoction (19). Another study revealed the
treatment efficacy of Jinxin Oral Liquid (JOL), modified
from Ma Xing Shi Gan decoction from traditional Chinese
medicines for pneumonia and asthma (20).
Moreover, Nigella sativa was also shown to possess
antiviral activity against hepatitis-C infection in patients
with type-2 diabetes. In a single-arm pilot study conducted
on type-2 diabetic patients, the administration of Nigella
sativa, instead of interferon/ribavirin therapy, significantly
reduced the viral load and improved oxidative stress
and glycemic control (21). Another study showed the
possible effects of Nigella sativa on immune-response
and pathogenesis of influenza virus subtype H9N2
(H9N2) on 130 non-vaccinated mixed-sex turkey poults.
Supplementation of Nigella sativa was found to reduce the
pathogenicity of influenza viruses and increased immune
responses (22). Similarly, Sinupret®, another naturopathic
mucolytic, has a wide range of antiviral activity in vitro
against respiratory viruses (23), and Lamiaceae is one
of the most important and well-known herbal families
because of numerous biological and medicinal effects that
could help prevent and treat some viral diseases (24).
Anti-SARS herbal compounds
Patients with SARS treated with traditional Chinese
medicines have been proven to take benefit from shorter
hospitalizations, fewer steroid-related side effects, and
improvement of symptoms. In this field, a study by Zhang et
al provided methods to identify several Chinese medicinal
plants categorized as antiviral/pneumonia-effective that
might directly prevent the COVID-19 infection (25).
They highlighted the prospect of computer-aided and
structure-based traditional Chinese medicinal drugs for
the novel coronavirus pneumonia. These methods assisted
in the combination and categorization of compounds into
a subclass, in a short amount of time with finite resources,
for the future clinical use of traditional Chinese medicinal
formulas (26).
Using the molecular docking modelling, Khaerunnisa
et al identified potential bioactive compounds against
COVID-19 via blocking protease in some medicinal
plants. The study showed nelfinavir, lopinavir, kaempferol,
quercetin, luteolin-7-glucoside, demethoxycurcumin,
naringenin, apigenin-7-glucoside, oleuropein, curcumin,
catechin, and epicatechin-gallate acted as the best potential
for COVID-19 main protease inhibitors (27).
It has also been suggested that many Indian medicinal
plants with antiviral, anti-inflammatory and antioxidant
properties could be favorable for the treatment of COVID
19. However, standard clinical trials are needed to prove
the efficacy of these herbs to manage the immune system.
Glycyrrhiza glabra, Allium sativum, Clerodendrum inerme
Gaertn, and Strobilanthes cusia seem to be alternative
candidates against COVID-19 by targeting the viral
Journal of Nephropharmacology, Volume 10, Issue 2, 2021
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replication of SARS coronavirus, inactivating the viral
ribosome, blocking the viral RNA genome synthesis and
inducing protease activity (28). Keyaerts et al evaluated
a special collection of 33 plant lectins with different
specificities. Herbal lectins presented a selective and
potent anti-coronavirus activity by interfering in the viral
replication cycle (29).
In their review, Lin et al found that several natural and
herbal medicines had antiviral effects on COVID-19.
These herbs included: Artemisia annua, Lycoris radiata,
Pyrrosia lingua, and Lindera aggregata, Isatis indigotica,
Torreya nucifera, myricetin, scutellarin and Houttuynia
cordata (30). Another study showed that viral loads and
replication of SARS coronavirus were decreased after
treatment with Anthemis hyalina, Nigella sativa and peels
of Citrus sinensis extracts. Anthemis hyalina extract is
the best candidate and could be used in highly effective
drugs against coronavirus and other viruses. In addition,
a mixture of Nigella sativa and honey has the ability to
improve respiratory tract infections (31).
The development of anti-SARS coronavirus agents is
essential to combat the pandemic of COVID- 19. Using
a cell-based assay on Vero E6 cells measuring SARS
coronavirus induced cytopathogenic effect in vitro, Wen
et al tested over 200 Chinese medicinal extracts. Six herbal
extracts, one from Gentianae radix, Dioscoreae rhizoma,
Cassiae semen and Loranthi ramus and two from Rhizoma
Cibotii, were found to be potent inhibitors of SARScoronavirus (32). Several important herbal resources
against SARS coronavirus are summarized in Table 1.
Herbals with beneficial effects on inflammatory
markers like Allium sativum and Ocimum basilicum may
be effective in the treatment of inflammatory phase of
COVID-19 (42).
Conclusion
Currently, there are no specific vaccines or antiviral

treatments for COVID-19 and no vaccine is expected to
be ready for months. A discovery of novel antivirals which
are highly efficient and economical for the supervision
and control of viral infections are absolutely essential in
the absence of vaccines and standard therapies. Therefore
prophylactic care and self-resistance are the main ways to
preserve personal protection and immunity. Furthermore,
the development of anti-SARS coronavirus herbal agents
seems to be inevitable in protecting against the COVID
-19 pandemic disease because of the structural similarity
of these two viruses.
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